Table 3.
Toxicity | Grade 1 | Grade 2 | Grade 3 | |
---|---|---|---|---|
n (%) | n (%) | n (%) | ||
During treatment n = 42 |
Dermatitis | 4 (9) | 3 (7) | 0 |
Skin reaction(s) | 4 (9) | 5 (11) | 0 | |
Hepatitis | 0 | 1 (2) | 1 (2) | |
Urinary incontinence/ urinary retention |
5 (11) | 0 | 0 | |
Diarrhoea | 7 (16) | 0 | 1 (2) | |
Dysphasia | 1 (2) | 0 | 0 | |
Pain | 7 (17) | 0 | 0 | |
Tiredness/fatigue | 9 (21) | 1 (2) | 0 | |
Three months after treatment n = 29 |
Dermatitis | 1 (3) | 0 | 0 |
Skin reaction(s) | 3 (10) | 0 | 0 | |
Diarrhoea | 2 (7) | 0 | 0 | |
Urinary incontinence/ urinary retention |
4 (14) | 0 | 0 | |
Pain | 3 (10) | 2 (7) | 0 |